United Therapeutics (UTHR), DEKA Report Additional FDA Clearance Related to Unity Subcutaneous Delivery System for Remodulin
Go back to United Therapeutics (UTHR), DEKA Report Additional FDA Clearance Related to Unity Subcutaneous Delivery System for Remodulin| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 544.33 +6.03 (1.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $538.30 | 52 Week High | $164.04 | |||
| Open | $542.08 | 52 Week Low | $97.52 | |||
| Day High | $546.58 | P/E | 99.51 | |||
| Day Low | $539.70 | EPS | $5.47 | |||
| Volume | 1,081,315 | |||||
